|

Microneedle Array Doxorubicin (MNA-D) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Doxorubicin, MNA-D, Patch

Pipeline

Phase 1/2: 1

Top Sponsors

  • Falo, Louis, MD1

Indications

  • Skin Cancers - Squamous Cell Carcinoma1
  • Cutaneous Squamous Cell Carcinoma1
  • Cancer1

Pittsburgh, Pennsylvania1 trial

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

University of Pittsburgh Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.